Live Analyst Rating Changes 1525 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Damian McNeela
DB
Damian McNeela
Deutsche Bank
Wall Street Analyst
Not yet ranked — too few measurable calls.
50%
Success Rate
+9.7%
Average Return
1 of 2 calls profitable · -0.4% vs benchmark
🔒 5-year track record is Pro. Showing 1-year — upgrade.
📈 Across the calls we could measure, roughly 50% of Damian McNeela's ratings turned a profit when each position was held for 1 year — averaging +9.7% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

21 Buy 3 Hold 0 Sell
Damian's Stock Coverage 18 ratings · 2026-06-19
Company Date Position Consensus ⓘ Price Target ⓘ 1-Yr Return
GB:CWK
Cranswick
 May 20, 2026 BUY Buy
+1.3% avg upside
3 analysts
$6100.00
11.48% Upside
 ·
MO
Altria Group
 May 04, 2026 HOLD Hold
-9.9% avg upside
23 analysts
$66.00
4.55% Downside
 -4.4%
GLAPF
Glanbia
 Apr 30, 2026 BUY Strong Buy
-25.7% avg upside
9 analysts
$24.97
3.94% Downside
 ·
GB:TET
Treatt plc
 Mar 27, 2026 HOLD Hold
-29.2% avg upside
1 analyst
$215.00
29.20% Downside
 ·
GB:BATS
British American Tobacco
 Mar 26, 2026 BUY Strong Buy
+573.2% avg upside
17 analysts
$5100.00
15.94% Upside
 ·
GB:FEVR
Fevertree Drinks
 Mar 25, 2026 HOLD Hold
+48.0% avg upside
17 analysts
$900.00
8.51% Upside
 ·
GB:CCR
C&C Group Plc
 Jan 26, 2026 BUY Strong Buy
+4.0% avg upside
3 analysts
$150.00
53.83% Upside
 ·
GB:GNS
Genus plc
 Jan 16, 2026 BUY Buy
+3959.4% avg upside
3 analysts
$3300.00
51.86% Upside
 ·
GB:HFG
Hilton Food
 Sep 30, 2025 BUY Buy
+55.5% avg upside
2 analysts
$1105.00
115.18% Upside
 ·
GB:PFD
Premier Foods
 Aug 21, 2025 BUY Buy
+18.3% avg upside
2 analysts
$240.00
19.77% Upside
 ·
GB:APN
Applied Nutrition PLC
 Aug 20, 2025 BUY Strong Buy
-36.3% avg upside
1 analyst
$190.00
36.27% Downside
 ·
GB:PZC
PZ Cussons
 Jun 27, 2025 BUY Strong Buy
+11.8% avg upside
1 analyst
$120.00
11.84% Upside
 ·
SNDVF
Scandinavian Tobacco Group
 May 21, 2025 HOLD Strong Sell
+55.4% avg upside
2 analysts
$13.98
36.47% Upside
 ·
GB:GNC
Greencore
 Apr 02, 2025 BUY Buy
+2286.2% avg upside
5 analysts
$245.00
23.16% Upside
 ·
GB:IMB
Imperial Brands
 Mar 28, 2025 BUY Strong Buy
+1493.8% avg upside
17 analysts
$3250.00
17.89% Upside
 ·
GB:TATE
Tate & Lyle
 Dec 11, 2024 BUY Buy
+4.0% avg upside
8 analysts
$950.00
71.88% Upside
 ·
PM
Philip Morris
 Oct 22, 2024 BUY Strong Buy
-4.4% avg upside
22 analysts
$142.00
20.32% Downside
 +23.8%
ASBFY
Associated British Foods
 Jan 12, 2017 BUY Buy
5 analysts
 — ·
🔒 13 more ratings — with price targets, crowd consensus and our measured returns.
Sign in free to unlock See Pro plans
Free account unlocks every analyst's full coverage table.
Damian McNeela — Frequently Asked Questions
How accurate are Damian McNeela's stock ratings?
Based on the calls 13Foresight could measure, about 50% of Damian's ratings were profitable over a one-year hold, with an average return of +9.7% per rating, or -0.4% versus the S&P 500. We score every analyst the same way, from historical prices.
How is Damian ranked on 13Foresight?
Damian McNeela is currently ranked unranked . Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Damian cover?
Damian most recently has ratings on GB:CWK, MO, GLAPF, GB:TET, GB:BATS, GB:FEVR, GB:CCR, GB:GNS, GB:HFG, GB:PFD, GB:APN, GB:PZC and 6 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.